Is Johnson & Johnson's (NYSE:JNJ) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Most readers would already be aware that Johnson & Johnson's (NYSE:JNJ) stock increased significantly by 11% over ...
Johnson & Johnson Sees Unusually High Options Volume (NYSE:JNJ)
Johnson & Johnson (NYSE:JNJ – Get Free Report) was the target of some unusual options trading on Thursday. Stock traders purchased 58,414 call options on the stock. This is an increase of ...
Trump tells Big Pharma to bring production home or face tariffs: Bloomberg News
President Donald Trump has warned a group of major U.S. drugmakers that his administration is set to impose tariffs on ...
FDA said to be reversing terminations made last week
The FDA reverses termination notices sent to probationary employees last week, calling them to return to work as early as ...
European Banks Swarm Dollar Market For AT1 Debt: Credit Weekly
European banks have turned to the US dollar market to sell almost $8 billion of bonds that help them boost capital levels.
Walmart's worst week since 2022: Retailer's former U.S. CEO Bill Simon thinks Wall Street is getting earnings, tariff risks wrong
Walmart shares just saw their worst weekly performance since May 2022 — tumbling almost 9%. The stock price fell more than 6% ...
Hosted on MSN3h
Johnson & Johnson’s TREMFYA® Shows Promising Results in Ulcerative Colitis Patients
Johnson & Johnson (NYSE: JNJ) has announced positive results from the Phase 3 ASTRO study evaluating TREMFYA® (guselkumab) ...